Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study

Lau, WCY; Torre, CO; Man, KKC; Stewart, HM; Seager, S; Van Zandt, M; Reich, C; Li, J; Brewster, J; Lip, GYH; Hingorani, AD; Wei, L; Wong, ICK

Wong, ICK (通讯作者),Univ Hong Kong, Pokfulam, L2-57,Lab Block,21 Sassoon Rd, Hong Kong, Peoples R China.

ANNALS OF INTERNAL MEDICINE, 2022; 175 (11): 1515

Abstract

Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over warfarin in patients with atrial fibrillation (AF), but head-to......

Full Text Link